Summary of characteristics and major results of the included studies.
收藏NIAID Data Ecosystem2026-03-07 收录
数据链接：
官方服务：
资源简介：
Abbreviations: Pts, patients; sign, significant; Exp, experimental arm; G, Gefitinib; E, erlotinib; Bev, bevacizumab; PFS, progression free survival in months; OS, overall survival in months; AE, adverse event; NR, not reported. †This ratio was based on the all included patients in IFCT-GFPC 0502, n = 464.
创建时间：
2013-03-21
